UiPath (PATH) CEO sells 45,000 shares at $15.7171 under 10b5-1
UiPath (PATH) insider activity: CEO and Chairman (also a 10% owner) reported selling 45,000 shares of Class A common stock on 10/31/2025 at an average price of $15.7171.
Rhea-AI Filing Summary
UiPath (PATH) insider activity: CEO and Chairman (also a 10% owner) reported selling 45,000 shares of Class A common stock on 10/31/2025 at an average price of $15.7171. The transaction was executed pursuant to a qualified Rule 10b5-1 trading plan.
Following the sale, the reporting person beneficially owns 29,423,585 shares, held directly. The filing notes the sale prices ranged from $15.5700 to $15.8500, with full trade-by-trade details available upon request.
Positive
- None.
Negative
- None.
Insights
Pre-planned 10b5-1 sale; holdings remain large post-transaction.
The CEO/Chairman disclosed a sale of 45,000 Class A shares on 10/31/2025 at an average of $15.7171. The sale was made under a qualified Rule 10b5-1 plan, indicating it was pre-arranged under preset trading instructions.
Post-transaction beneficial ownership is 29,423,585 shares held directly. The price range was $15.5700 to $15.8500. This disclosure documents insider activity and plan compliance; actual market impact depends on context not provided in the excerpt.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 45,000 | $15.7171 | $707K |
Footnotes (2)
- F1. These shares were sold in compliance with a qualified selling plan adopted by the Reporting Person pursuant to Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- F2. The range of prices for the transactions reported was from $15.5700 to $15.8500. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did UiPath (PATH) disclose in this insider filing?
Was the UiPath (PATH) insider sale part of a 10b5-1 plan?
What price range did the PATH insider sales occur at?
What roles does the reporting person hold at UiPath (PATH)?
How is ownership held after the PATH insider transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.